Mouse Monoclonal Antibody to Bi-Phospho-MET/HGFR(Y1234/Y1235) (Clone: 6AT1877)(Discontinued)
Figure 1: Detection of endogenous Met antibody (10-6501) in HepG2 cell line. 10 μg/lane of HepG2 cell lysate was used to examine the expression of human Met. Lanes 1-5 represent different anti-Met monoclonal antibodies and Lane 6 represents auto-phosohorylated-Met in HepG2 cell line detected by anti-phospho-Met Mab.
Roll over image to zoom in
|Amount :||400 µl|
|Isotype :||Mouse IgG1|
|Purification :||Protein G Chromatography|
|Content :||Purified monoclonal antibody supplied in PBS with 0.09% (W/V) sodium azide.|
|Storage condition :||Maintain refrigerated at 2-8°C for up to 2 weeks. For long term store at -20°C in small aliquots to prevent freeze-thaw cycles.|
The proto-oncogene MET product is the hepatocyte growth factor receptor and encodes tyrosine-kinase activity. The primary single chain precursor protein is post-translationally cleaved to produce the alpha and beta subunits, which are disulfide linked to form the mature receptor. Various mutations in the MET gene are associated with papillary renal carcinoma. Two transcript variants encoding different isoforms have been found for this gene.
For Research Use Only. Not for use in diagnostic/therapeutics procedures.
|Post transnational modification:||(Microbial infection) Tyrosine phosphorylation is stimulated by L.monocytogenes InlB. Tyrosine phosphorylation is maximal 10-20 minutes after treatment with InlB and disappears by 60 minutes. The phosphorylated residues were not identified.|
|Tissue Specificity:||Expressed in normal hepatocytes as well as in epithelial cells lining the stomach, the small and the large intestine. Found also in basal keratinocytes of esophagus and skin. High levels are found in liver, gastrointestinal tract, thyroid and kidney. Also present in the brain. Expressed in metaphyseal bone (at protein level) (PubMed:26637977).|
|BioGrid:||110391. 67 interactions.|